Press Releases

Debiopharm to showcase research results of their DDR Inhibitors at the 2024 AACR Conference in San Diego

Debiopharm Launches Expansion of WEE1 Inhibitor Monotherapy Research in Gynecological Cancers and Other Biomarker-Driven Solid Tumors

Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide

Challenge pour la Qualité de vie du patient 2024, l’appel à projets est ouvert

TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Debiopharm and ThinkingNodeLife.ai Forge Strategic Partnership to Propel Cancer Drug Development

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers